Search Results

Abbott Liquid CSF Control is intended for use as a quality control to monitor the Abbott Eiquid OCF Ochiretto procedures for the analytes listed in the value sheet.

Not Found

The provided document is a 510(k) clearance letter from the FDA for the "Abbott Liquid CSF Control" device. This letter indicates that the device has been found substantially equivalent to a legally marketed predicate device.

However, the letter does not contain any information regarding acceptance criteria, device performance studies, sample sizes, ground truth establishment, expert qualifications, or MRMC studies.

This type of FDA letter is an administrative confirmation of substantial equivalence based on information submitted by the manufacturer in their 510(k) notification. It summarizes the regulatory determination, but it does not detail the technical performance data or specific study design elements that would have been part of the manufacturer's submission.

Therefore, I cannot extract the requested information from the provided text. To answer your questions, one would need access to the actual 510(k) submission document itself, which would contain the performance data and study details.

Ask a specific question about this device